Opportunity Information: Apply for PA 20 070

This funding opportunity, PA-20-070, is an AHRQ (Agency for Healthcare Research and Quality) announcement offering competitive revision supplements to organizations that already hold active AHRQ health services research (HSR) grants or cooperative agreements. The central goal is to quickly add targeted, COVID-19-focused work to ongoing AHRQ-funded projects so investigators can respond to urgent, real-world needs in how health systems and healthcare professionals adapted during the COVID-19 public health crisis. The supplements are meant to accelerate timely evidence generation about what worked, what failed, and what can be improved in healthcare delivery and workforce response under pandemic conditions. Clinical trials are optional under this supplement mechanism, meaning applicants may propose studies that include clinical trial elements if appropriate, but they are not required to do so.

A key point is that this program is specifically for revisions to existing AHRQ awards, not brand-new standalone projects. It is also limited by award type: certain AHRQ mechanisms are excluded, including R13 conference grants as well as T32 and F32 training and fellowship awards. In addition, the announcement explicitly excludes projects that were originally funded under AHRQ FOAs supported by the Patient-Centered Outcomes Research Trust Fund (PCOR TF) dollars. For those PCOR TF-supported grants, AHRQ directed applicants to a separate opportunity (PA-20-072). In practice, that means eligibility depends not only on having an active AHRQ award, but also on the funding source and mechanism of that award.

The supplement’s research focus is on evaluating health system and healthcare professional responsiveness to COVID-19. While the short description does not list detailed topic areas, the intent is clearly to support rapid, applied health services research examining healthcare delivery and workforce performance during COVID-19, such as how organizations adjusted care processes, protected staff, maintained essential services, managed capacity constraints, implemented telehealth or new triage workflows, addressed supply chain disruptions, or responded to evolving guidance. Because these are competitive revisions, applications would generally need to demonstrate that the proposed COVID-19 work is tightly connected to the aims, data resources, partnerships, or infrastructure of the parent AHRQ-funded project, and that the supplement will produce actionable findings on a compressed timeline.

Eligibility is broad in terms of institution types, but still bounded by the “active AHRQ award” requirement and the non-U.S. restrictions. The opportunity lists many eligible applicant categories that include state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. It also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly states that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible, which narrows participation to U.S.-based applicants and operations.

From an administrative perspective, this is a discretionary grant opportunity under the health funding activity category, associated with CFDA 93.226. The issuing agency is AHRQ. The original closing date listed is May 31, 2020, and the FOA was created on April 29, 2020, reflecting the rapid-turnaround nature of early-pandemic funding actions. The published excerpt does not provide an award ceiling or expected number of awards, so applicants would need to consult the full FOA for budget limits, allowable costs, the maximum supplement amount relative to the parent award, project period constraints, and application instructions. Overall, PA-20-070 is best understood as an emergency-response supplement mechanism designed to quickly extend existing AHRQ-funded HSR projects to capture and evaluate how healthcare systems and clinicians responded to COVID-19, with the expectation that results will inform near-term improvements and preparedness for future public health disruptions.

  • The Agency for Health Care Research and Quality in the health sector is offering a public funding opportunity titled "Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226.
  • This funding opportunity was created on 2020-04-29.
  • Applicants must submit their applications by 2020-05-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 20 070

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Healthcare Providers

Browse more opportunities from the same agency: Agency for Health Care Research and Quality

Browse more opportunities from the same category: Health

Next opportunity: Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)

Previous opportunity: Regional Food System Partnerships

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 20 070

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 20 070) also looked into and applied for these:

Funding Opportunity
Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) Apply for RFA HS 20 003

Funding Number: RFA HS 20 003
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) Apply for RFA AI 20 029

Funding Number: RFA AI 20 029
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required) Apply for RFA HL 22 006

Funding Number: RFA HL 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 20 019

Funding Number: RFA RM 20 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Noninvasive mTBI Tool RFI Apply for HU000120R0047

Funding Number: HU000120R0047
Agency: Uniformed Services Univ. of the Health Sciences
Category: Health
Funding Amount: Case Dependent
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) Apply for PAR 20 175

Funding Number: PAR 20 175
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Apply for RFA AI 20 027

Funding Number: RFA AI 20 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 072

Funding Number: PA 20 072
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Apply for PAR 20 178

Funding Number: PAR 20 178
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Apply for PAR 20 177

Funding Number: PAR 20 177
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) Disease Modifying Therapies for Chronic Lung Diseases (U24 Clinical Trial Required - Infrastructure) Apply for RFA HL 21 012

Funding Number: RFA HL 21 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required) Apply for RFA HL 21 013

Funding Number: RFA HL 21 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Frontier Health Markets (FHM) Apply for RFI 20 GH FHM 01

Funding Number: RFI 20 GH FHM 01
Agency: Agency for International Development
Category: Health
Funding Amount: $250,000,000
Research Program Award (R35 Clinical Trial Optional) Apply for RFA NS 20 030

Funding Number: RFA NS 20 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) Apply for PAR 20 209

Funding Number: PAR 20 209
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) Apply for PAR 20 210

Funding Number: PAR 20 210
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) Apply for RFA RM 20 011

Funding Number: RFA RM 20 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 20 012

Funding Number: RFA RM 20 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 20 215

Funding Number: PAR 20 215
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Apply for PAR 20 217

Funding Number: PAR 20 217
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,050,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 20 070", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: